The short answer
A universal one-to-two-hour gap between Lactobacillus and cefuroxime has not been established by the studies checked. Probiotic results depend on the strain and preparation, and trials show mixed benefits. Review the actual product and schedule rather than assuming every Lactobacillus supplement is interchangeable.
What this answer covers
Cefuroxime exposure and oral or feeding-tube Lactobacillus preparations. Available studies include mixed antibiotics, specific strains and sometimes other organisms; they do not isolate a universal cefuroxime timing effect.
- Supplement or preparation
- Lactobacillus
- Medication ingredient
- cefuroxime
What does the proposed interval mean?
The imported claim specifies one to two hours, but no study inspected compared that gap against simultaneous cefuroxime dosing. In the positive Hickson trial, a one-to-two-hour instruction concerned meals, not separation from the antibiotic. That detail cannot establish the requested drug-to-probiotic interval.
Have probiotics been studied during antibiotic treatment?
Yes. A small trial of a drink containing specific Lactobacillus strains and another organism reported less diarrhea. A small ICU feasibility study also included a few cefuroxime-treated patients. Both used particular products and mixed antibiotic regimens, so neither proves a cefuroxime-specific effect for the whole genus.
Were the results consistently beneficial?
No. The much larger PLACIDE trial found no reduction in antibiotic-associated diarrhea with its lactobacilli/bifidobacteria preparation. Differences in strains, dose and study populations matter. The mixed evidence does not justify prescribing an arbitrary Lactobacillus product or promising protection during cefuroxime treatment.
What if diarrhea develops?
Cefuroxime labeling warns that antibiotic-associated diarrhea can sometimes reflect C. difficile infection. Seek clinical advice for significant, persistent or worsening diarrhea rather than relying on a probiotic alone. Keep taking medicines according to the treating team’s instructions and show them the exact probiotic product before arranging co-use.
Evidence and practical considerations
Timing & monitoring
A universal one-to-two-hour gap between Lactobacillus and cefuroxime has not been established by the studies checked. Probiotic results depend on the strain and preparation, and trials show mixed benefits. Review the actual product and schedule rather than assuming every Lactobacillus supplement is interchangeable.
- Exact scope
- Cefuroxime exposure and oral or feeding-tube Lactobacillus preparations. Available studies include mixed antibiotics, specific strains and sometimes other organisms; they do not isolate a universal cefuroxime timing effect. with cefuroxime in mixed oral or parenteral antibiotic regimens; no route-specific interval established
- Medication form and route
- oral; parenteral
- Timing or duration
- During co-use; study-specific durations are retained in the source summaries. No universal duration or dose-response inferred.
What remains uncertain
- No randomized cefuroxime/probiotic interval comparison or genus-wide efficacy result. Positive and negative trials use distinct mixtures and populations; small studies do not establish safety in every high-risk patient.
Factors that may matter: exact probiotic strain and organism mixture; patient population; concurrent antibiotics; probiotic dose and duration.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People receiving oral cefuroxime axetil tablets.
Reduced stomach acidity can lower oral bioavailability. Administer antibiotic at least one hour before or two hours after short-acting antacids. Label also warns about C. difficile-associated diarrhea.
How this applies: RxCUI 2194 active cefuroxime is reached after oral axetil conversion. Gastric-pH effect is restricted to oral axetil, not injected cefuroxime sodium. Exact package scope: Cefuroxime exposure and oral or feeding-tube Lactobacillus preparations. Available studies include mixed antibiotics, specific strains and sometimes other organisms; they do not isolate a universal cefuroxime timing effect.
Antacid class precaution does not quantify the effect of every mineral salt; tablets and suspension are not interchangeable milligram for milligram.
Source 2: randomized placebo-controlled trial
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 135 hospitalized adults older than 50 randomized; 113 had diarrhea outcome data.
Antibiotic-associated diarrhea occurred in 12% versus 34% of analyzed probiotic and placebo groups.
How this applies: Supports preparation-specific probiotic research but not a universal one-to-two-hour cefuroxime/probiotic separation rule. Exact package scope: Cefuroxime exposure and oral or feeding-tube Lactobacillus preparations. Available studies include mixed antibiotics, specific strains and sometimes other organisms; they do not isolate a universal cefuroxime timing effect.
Mixed antibiotics and probiotic species, incomplete follow-up, no cefuroxime-specific effect or randomized dose-separation comparison. The one-to-two-hour instruction in methods concerns meals.
Source 3: small matched-control feasibility study
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 32 ICU patients, 16 per group.
Descriptively fewer diarrhea events with the drink; sample was designed for feasibility.
How this applies: Demonstrates actual cefuroxime co-exposure without proving a genus-wide effect or precise timing rule. Exact package scope: Cefuroxime exposure and oral or feeding-tube Lactobacillus preparations. Available studies include mixed antibiotics, specific strains and sometimes other organisms; they do not isolate a universal cefuroxime timing effect.
Nonrandomized small study, mixed antibiotics, no cefuroxime subgroup effect and no antibiotic/probiotic interval comparison.
Source 4: multicentre randomized placebo-controlled trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 2,941 analyzed inpatients aged at least 65, exposed to oral or parenteral antibiotics.
Antibiotic-associated diarrhea was 10.8% versus 10.4%; relative risk 1.04, 95% CI 0.84-1.28. No demonstrated benefit.
How this applies: Retains large negative probiotic trial rather than presenting all Lactobacillus products as effective with cefuroxime. Exact package scope: Cefuroxime exposure and oral or feeding-tube Lactobacillus preparations. Available studies include mixed antibiotics, specific strains and sometimes other organisms; they do not isolate a universal cefuroxime timing effect.
Different strains and regimen from positive trials; no isolated cefuroxime effect or timing comparison.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Removes the unsupported fixed one-to-two-hour timing requirement, identifies the meal-timing confusion and retains contrary probiotic trial evidence. | |
| Research summary published |
Article revision: b7e8a3d7f0961646
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.